• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. VENA CAVA FILTER Back to Search Results
Catalog Number UNKNOWN FILTER
Device Problems Migration or Expulsion of Device (1395); Difficult to Remove (1528); Obstruction of Flow (2423)
Patient Problem Thrombus (2101)
Event Date 04/29/2014
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history record (dhr) could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.The medical records included images.The image review was documented in the medical records.Medical records were provided and reviewed.Approximately one month post filter deployment, ct revealed that the infrarenal ivc was expanded with intraluminal thrombus which extended at least to the level of the filter and intraluminal hypo density within the suprarenal ivc which favored to be due to inflow phenomenon, although extension of thrombus could not be entirely excluded.Approximately two months later, patient scheduled for filter retrieval.Subsequent inferior vena cavogram revealed chronic occlusion of the ivc which encased majority of the filter.Hence, procedure was eventually aborted.Therefore, the investigation is confirmed for occlusion of the ivc filter.However, the investigation is inconclusive for filter migration, retrieval difficulties, filter tilt, perforation of the ivc.Additionally, it can be confirmed that the patient experienced thrombus above the filter post deployment.However, the relationship to the filter is unknown.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism.At some time post filter deployment, it was alleged that the filter occluded, tilted, migrated to renal vein and struts perforated into the organs.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis/pulmonary embolism and in conjunction with trauma situation/motor vehicle accident.At some time post filter deployment, it was alleged that the filter occluded, tilted, migrated to renal vein and struts perforated into the organs.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Manufacturer Narrative
Manufacturing review: the device history record (dhr) could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.The medical records included images.The image review was documented in the medical records.Medical records were provided and reviewed.Approximately one month post filter deployment, ct revealed that the infrarenal ivc was expanded with intraluminal thrombus which extended at least to the level of the filter and intraluminal hypo density within the suprarenal ivc which favored to be due to inflow phenomenon, although extension of thrombus could not be entirely excluded.Approximately two months later, patient scheduled for filter retrieval.Subsequent inferior vena cavogram revealed chronic occlusion of the ivc which encased majority of the filter.Hence, procedure was eventually aborted.Therefore, the investigation is confirmed for occlusion of the ivc filter.However, the investigation is inconclusive for filter migration, retrieval difficulties, filter tilt, perforation of the ivc.Additionally, it can be confirmed that the patient experienced thrombus above the filter post deployment.However, the relationship to the filter is unknown.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(device: 2616 and 4001).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA CAVA FILTER
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key9669463
MDR Text Key178357032
Report Number2020394-2020-00847
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Type of Report Initial,Followup
Report Date 04/08/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN FILTER
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/07/2020
Initial Date FDA Received02/05/2020
Supplement Dates Manufacturer Received03/20/2020
Supplement Dates FDA Received04/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age32 YR
-
-